Drug
Vancomycin Oral
Vancomycin Oral is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (75.0%)
N/A1 (25.0%)
Trials by Status
completed250%
withdrawn125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnphase_4
Bezlotoxumab Versus FMT for Multiple Recurrent CDI
NCT05077085
completedphase_4
Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection
NCT03880539
unknownnot_applicable
The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery
NCT03939273
completedphase_4
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
NCT02951702
Clinical Trials (4)
Showing 4 of 4 trials
NCT05077085Phase 4
Bezlotoxumab Versus FMT for Multiple Recurrent CDI
NCT03880539Phase 4
Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection
NCT03939273Not Applicable
The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery
NCT02951702Phase 4
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4